Stuttgart - Delayed Quote EUR

CRISPR Therapeutics AG (1CG.SG)

37.20
+1.60
+(4.49%)
As of 8:58:32 AM GMT+2. Market Open.
Loading Chart for 1CG.SG
  • Previous Close 35.60
  • Open 36.00
  • Bid --
  • Ask --
  • Day's Range 36.00 - 37.20
  • 52 Week Range 29.40 - 40.80
  • Volume 74
  • Avg. Volume 159
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 1CG.SG

View more

Performance Overview: 1CG.SG

Trailing total returns as of 6/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

1CG.SG
8.82%
S&P 500 (^GSPC)
1.62%

1-Year Return

1CG.SG
8.82%
S&P 500 (^GSPC)
10.04%

3-Year Return

1CG.SG
8.82%
S&P 500 (^GSPC)
63.00%

5-Year Return

1CG.SG
8.82%
S&P 500 (^GSPC)
91.28%

Compare to: 1CG.SG

Select to analyse similar companies using key performance metrics; select up to four stocks.

Statistics: 1CG.SG

View more

Valuation Measures

Annual
As of 6/13/2025
  • Market Cap

    3.08B

  • Enterprise Value

    1.67B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    100.75

  • Price/Book (mrq)

    1.95

  • Enterprise Value/Revenue

    55.32

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1CG.SG

View more

Company Insights: 1CG.SG

Research reports: 1CG.SG

View more